Clinical Trials Browser

Phase 3 × Leukemia, Myeloid, Chronic-Phase × olverembatinib × Clear all

NCT06423911 2025-06-03

POLARIS-2

Phase 3 Recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT05311943 2022-07-29

Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs.

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase